Dublin Core PKP Metadata Items Metadata for this Document
 
1. Title Title of document Compensation for trial-related injury: does simplicity compromise fairness?
 
2. Creator Author's name, affiliation, country Mala Ramanathan; AMCHSS, SCTIMST, Medical College PO, Thiruvananthapuram 695 011; IN
 
3. Subject Discipline(s)
 
3. Subject Keyword(s)
 
4. Description Abstract India’s regulatory framework for research ethics is two pronged. Schedule Y of the Drugs and Cosmetics Act, 1940, of the Government of India, lays down the requirements for undertaking clinical trials for drugs and medical devices in India; it also requires compliance with the ICMR’s Ethical guidelines for biomedical research on human participants for such trials. Other health research may use the ICMR’s guidelines but this is not mandatory. The regulatory framework is operationalised through the offices of the Central Drugs Standard Control Organisation. However, the mechanisms of monitoring drug trials using this framework have proved to be rather weak.
 
5. Publisher Organizing agency, location Forum for Medical Ethics Society
 
6. Contributor Sponsor(s)
 
7. Date (YYYY-MM-DD) 2016-11-30
 
8. Type Status & genre
 
8. Type Type
 
9. Format File format HTML , PDF
 
10. Identifier Uniform Resource Identifier https://ijme.in/articles/compensation-for-trial-related-injury-does-simplicity-compromise-fairness/
 
11. Source Title; vol., no. (year) Indian Journal of Medical Ethics;: Strengthening the core
 
12. Language English=en en
 
13. Relation Supp. Files
 
14. Coverage Geo-spatial location, chronological period, research sample (gender, age, etc.)
 
15. Rights Copyright and permissions

All articles published in IJME are available on its website free of charge. The copyright for published material belongs to IJME/FMES. IJME freely permits the reprint (or reproduction on a website) of articles from the journal, as long as this is for non-commercial use and appropriate credit is given to the author and the journal and publication details are mentioned. The commercial use of our content can be made only after obtaining permission from and on payment to IJME. This is intended to support production of the journal.